[Clinical Gastroenterology] Inflammatory Bowel Disease || The Economics of Inflammatory Bowel Disease
- 作者Cohen, Russell D.
- 文件大小198.86KB
- 发表时间2017
- DOI10.1007/978-3-319-53763-4_21
- 页码345-355
BacktalkRobert Effler, Edwin T. Greninger, Mark T. Pattie, Jr., Patrick D. Lynch, Joseph D'Amico, Merton L. Bland, John D. McNeil, Robert D. Russell, William E. Albright, Donna V. Cohen, Daniel D. Levine, Wm. Clark Trow and Rowena Babcock · The Phi Delta Kappan · 1974
Managing Immunogenic Responses to InfliximabPeter D. Han, Dr Russell D. Cohen · 2004
Thalidomide therapy for patients with refractory Crohn's disease: An open-label trialEli D. Ehrenpreis; Sunanda V. Kane; Lawrence B. Cohen; Russell D. Cohen; Stephen B. Hanauer · 1999
Evolving medical therapies for ulcerative colitisPhillip Y. Chung; Russell D. Cohen · 2001
Evolving medical therapies for ulcerative colitisRussell D. Cohen · 2002
Management of refractory ulcerative colitisSunana Sohi; Russell D. Cohen · 2006
Response:David T. Rubin; Russell D. Cohen; Stephen B. Hanauer · 2008
IBD researchers reach for the “tabloid”Russell D. Cohen · 2004